
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+8
The companys lead drug AVM0703, a proprietary innovative formulation of dexamethasone, when given at supra-pharmacologic doses has a novel mechanism of action to mobilize the bodys own natural supercharged immune cells. AVM0703 triggers the production and release of endogenous gamma delta TCR+ invariant TCR+ bispecific T lymphocytes and Natural Killer T cells and could be the first choice for no-option cancer, autoimmunity, and infectious disease. AVM Biotechnology was founded by Dr. Theresa Deisher with a personal mission to defeat cancer and has a Scientific Advisory Board including well-respected leaders in cancer and immunology. The company is committed to developing products...
R&d,drug discovery,stem cells,regenerative medicine,fully human biologics,personalized medicine,immunology,cancer,diabetes,autoimmunity,non-hodgkin lymphoma,natural killer t-cells,and gamma delta tcr+ invariant tcr+ bispecific t-lymphocytes
Avm biotechnology operates in the Biotechnology research industry.
Avm biotechnology's revenue is 11m - 100m
Avm biotechnology has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.